Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- biotechnology [1]
- Company / filing name
- Protalix BioTherapeutics, Inc. [2]
- Founded
- 1993 [1]
- Legal form
- limited company [1]
- Founders
- Joseph Chaaltiel [1]
- Official website
- http://www.protalix.com/; https://www.protalix.com [1]
- ISIN (reported securities)
- US74365A3095 [1]
- CIK
- 1006281 [2]
- Country in background record
- Israel [1]
- Symbols / exchanges
- PLX (NYSE) [2]
Company positioning and business
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. [3]
Background text: Wikipedia contributors, Protalix BioTherapeutics. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: PLX (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was Protalix BioTherapeutics, Inc. founded?
Founded: 1993. The linked source provides the background record. [1]
Which business sectors are recorded for Protalix BioTherapeutics, Inc.?
Business sectors: biotechnology. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Protalix BioTherapeutics (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.